CLINDASEPTIN 25 MG/ML ORAL SOLUTION FOR CATS AND DOGS
CLINDASEPTIN 25 MG/ML ORAL SOLUTION FOR CATS AND DOGS
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
CLINDASEPTIN 25 MG/ML ORAL SOLUTION FOR CATS AND DOGS
Active substance:
- Clindamycin hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride27.15/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Package description:
- Carton box containing Type III amber glass bottle of 22 ml with a low density polyethylene measuring syringe
- Carton box containing clear polyethylene terephthalate (PET) bottle of 22 ml with a low density polyethylene measuring syringe
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/033/DC/12-S
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0236/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Germany
-
Ireland
-
Italy
-
Netherlands
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 28/03/2022
